CrossRef Immunometabolic reprogramming in diabetic osteomyelitis: from mechanisms to therapeutics Hui Zhang, Zi-Shan Fu, Ying Zhou, Song-Nan Wang, Si-Ying Ye, An-Na Wang, Jun-Tong Liu Frontiers in Cellular and Infection Microbiology.2025;[Epub] CrossRef Chronic Infections and Diabetes in Africa: A Narrative Review of Pathogen-Associated Metabolic Risk Olabisi P Lawal, Fortune I Ebiala, Modinat Abayomi, Obiageri Ihuarulam Okeoma, Nana Ama Aduma Amankwah, John O Patrick, Queeneth Eguakun, Aliyu O Olaniyi Cureus.2025;[Epub] CrossRef Original Articles Guideline/Statement/Fact Sheet 2025 Clinical Practice Guidelines for Diabetes Management in Korea: Recommendation of the Korean Diabetes Association Shinae Kang, Seon Mee Kang, Jong Han Choi, Seung-Hyun Ko, Bo Kyung Koo, Hyuk-Sang Kwon, Mi Kyung Kim, Sang Yong Kim, Soo-Kyung Kim, Young-eun Kim, Eun Sook Kim, Jae Hyeon Kim, Chong Hwa Kim, Ji Min Kim, Hae Jin Kim, Min Kyong Moon, Sun Joon Moon, Jun Sung Moon, Joon Ho Moon, Se Hee Min, Jung Hwan Park, Jaehyun Bae, Keeho Song, Ji Yoon Ahn, Jae-Seung Yun, Woo Je Lee, You-Bin Lee, Suk Chon, Eonju Jeon, Sang-Man Jin, Eugene Han, You-Cheol Hwang, Jae Hyun Bae, YoonJu Song, Jeong Hyun Lim, Jae Won Cho, Ji Yeon Choi, Yong Hee Hong, Jieun Lee, Sung Eun Kim, Ji Yun Noh, Bong-Soo Cha, Byung-Wan Lee Diabetes Metab J

The review also highlighted preclinical evidence that GLP-1 receptor activation can counteract reactive oxygen species and mitigate oxidative cytotoxicityprocesses that accelerate cellular injury across multiple neurodegenerative pathways
Anti-Obesity medications like Saxenda and Wegovy belong to a class of medications known as GLP-1 receptor agonists and have been gaining popularity as a weight-loss solution
Berberines antimicrobial properties kill bad bacteria and flush them out while cultivating good ones to take their place